Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.228EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.174EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.88 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.106 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.346EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.93EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.65 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.339EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.229EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.415EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.370EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.421EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.612EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.305EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.512EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.349EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.265EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.401EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.362EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.453EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used